Get the latest crypto news, updates, and reports by subscribing to our free newsletter.
Giấy phép số 4978/GP-TTĐT do Sở Thông tin và Truyền thông Hà Nội cấp ngày 14 tháng 10 năm 2019 / Giấy phép SĐ, BS GP ICP số 2107/GP-TTĐT do Sở TTTT Hà Nội cấp ngày 13/7/2022.
© 2026 Index.vn
Domestic gold prices opened the new week (April 6) with a broad decline from the previous week’s close, as world gold prices fell due to positive US jobs data, raising expectations that the Federal Reserve will keep interest rates high for longer. As of 13:45 on April 6, domestic gold…
The DJS Law Group has reminded investors of a class action lawsuit against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated by the U.S. Securities and Exchange Commission.
According to the complaint, the company made false and misleading statements to the market. The filing alleges that Aldeyra’s drug candidate, reproxalap, generated inconsistent results in clinical trials, and that the company’s positive statements about its clinical trials were unreliable. Based on these allegations, the complaint contends that Aldeyra’s public statements were false and materially misleading throughout the class period.
Shareholders who purchased shares of ALDX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to participate in any recovery.
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
